Premium
The evolving epidemic of breast cancer in sub‐Saharan Africa: Results from the African Cancer Registry Network
Author(s) -
JokoFru Walburga Yvonne,
JedyAgba Elima,
Korir Anne,
Ogunbiyi Olufemi,
Dzamalala Charles P.,
Chokuga Eric,
Wabinga Henry,
Manraj Shyam,
Finesse Anne,
Somdyala tuthuzelo,
Liu Biying,
McGale Paul,
Jemal Ahmedin,
Bray Freddie,
Parkin Donald Maxwell
Publication year - 2020
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.33014
Subject(s) - incidence (geometry) , demography , cancer registry , breast cancer , medicine , cohort , cancer , population , cumulative incidence , gynecology , environmental health , physics , sociology , optics
Breast cancer (BC) is the leading cause of cancer in sub‐Saharan Africa (SSA) with rapidly increasing incidence rates reported in Uganda and Zimbabwe. However, the magnitude of these rising trends in premenopausal and postmenopausal women is unknown in most African countries. We used data from the African Cancer Registry Network on incident breast cancers in women from 11 population‐based cancer registries in 10 countries representing each of the four SSA regions. We explored incidence changes among women before and after age 50 by calendar period and, where possible, generational effects in this unique sub‐Saharan African cohort. Temporal trends revealed increasing incidence rates in all registries during the study period, except in Nairobi where rates stabilised during 2010 to 2014 after rapidly increasing from 2003 to 2010 (APC = 8.5 95%, CI: 3.0‐14.2). The cumulative risk varied between and within regions, with the highest risks observed in Nairobi‐Kenya, Mauritius and the Seychelles. There were similar or more rapidly increasing incidence rates in women aged 50+ compared to women <50 years in all registries except The Gambia. Birth cohort analyses revealed increases in the incidence rates in successive generations of women aged 45 and over in Harare‐Zimbabwe and Kampala‐Uganda. In conclusion, the incidence of BC is increasing rapidly in many parts of Africa; however, the magnitude of these changes differs. These results highlight the need for urgent actions across the cancer continuum from in‐depth risk factor studies to provision of adequate therapy as well as the necessity of supporting the maintenance of good quality population‐based cancer registration in Africa.